Category Archives: COVID-19

What happened, proxalutamide? New antiandrogen for COVID-19 is entangled in clinical data irregularities and human rights violations

Posted on December 1, 2021 by Zinnia Jones

Disclaimer: I am not a medical professional and this is not medical advice. From the outset of the COVID-19 pandemic, there has been interest in a possible relationship between sex hormones and likelihood of infection or severity of disease. Cis … Continue reading →

Posted in Antiandrogens, COVID-19, Endocrinology, Ethics, News | Tagged , , , | Leave a comment

Trans Broken Brain Syndrome: When “subjective cognitive decline” becomes a subjective attack on trans healthcare

Posted on August 31, 2021 by Zinnia Jones

By Heather McNamara Have you ever looked at an object and forgotten what it was called? Maybe you’ve been in the produce section of a grocery store, standing in front of the pineapples and found yourself thinking “Banana? Mango?” I … Continue reading →

Posted in COVID-19, Media, Personal, Transgender medicine | Tagged , , , , , | Leave a comment

Zinnia’s college adventures, year 3: A Florida public university is forcing us into conditions of unchecked pandemic exposure

Posted on August 31, 2021 by Zinnia Jones

Previously: Zinnia goes to college, gets more knowledge (June 2019) Zinnia’s continued college adventures: summer 2019 (August 2019) Notes on my first two years at college as an adult learner (November 2020) I have been a student in the Florida … Continue reading →

Posted in COVID-19, Personal | Tagged | 1 Comment

AstraZeneca or not, cerebral venous sinus thrombosis is a complex and potentially fatal emergency. Is the world prepared?

Posted on April 1, 2021 by Zinnia Jones

Disclaimer: I am not a medical professional and this is not medical advice. The COVID-19 pandemic and investigations into the Oxford-AstraZeneca vaccine and blood clots are rapidly evolving situations. This information may be superseded by later findings. This article was … Continue reading →

Posted in COVID-19, Personal, Statistics and demographics | Tagged , , | 2 Comments

Proxalutamide, a new antiandrogen, improves COVID-19 outcomes in trials of men and women

Posted on February 28, 2021 by Zinnia Jones

Previously: COVID-19 updates: From spironolactone to estrogen to GnRH antagonists (May 2020) Disclaimer: I am not a medical professional and this is not medical advice. The COVID-19 pandemic continues to be a rapidly evolving situation, and this information may be … Continue reading →

Posted in Antiandrogens, COVID-19, Endocrinology | Tagged , , | Leave a comment